| Tavegil (clemastine) / GSK |
NCT01125761: Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis |
|
|
| Withdrawn | 3 | 0 | RoW | dexamethasone 0.5 mg and 1.0 mg clemastine cream, Dexamethasone 0,5 mg cream | Azidus Brasil | Dermatitis | 11/10 | 11/10 | | |
NCT01239719: Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis |
|
|
| Unknown status | 3 | 96 | NA | Dexamethasone + clemastine, Dexamethasone | Azidus Brasil | Allergy, Dermatitis | 07/11 | 12/11 | | |
NCT01257061: Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment |
|
|
| Completed | 3 | 310 | RoW | Group 1, Group 2 | EMS | Eczema | 04/13 | 08/13 | | |
2021-003677-66: Clemastine fumarate as a treament for eye movement disorders in patients with multiple sclerosis Clemastine fumaraat als behandeling voor een stoornis in de oogbewegingen bij patiënten met multiple sclerose |
|
|
| Not yet recruiting | 3 | 80 | Europe | Clemastine fumarate, Fampridine, Tablet, Clemastine Milstein 1 mg, tabletten, Fampyra 10 mg prolonged-release tablets | Amsterdam University Medical Center, Stichting VUmc Fonds | Multiple sclerosis (MS)Internuclear ophthalmoparesis (INO) Multiple sclerose (MS)Internucleaire oftalmoplegie (INO), Multiple sclerosis (MS)Eye movement disorder Multiple scleroseOogbewegingsstoornis, Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT06315699: Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome |
|
|
| Recruiting | 3 | 50 | RoW | Clemastine Fumarate Tablets, fructose | Qilu Hospital of Shandong University | Williams Syndrome, Child, Neurodevelopmental Delay | 03/25 | 12/25 | | |
RESTORE, NCT05338450: Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis |
|
|
| Recruiting | 3 | 80 | Europe | Clemastine Fumarate, clemastine, Tavegyl, Placebo | Amsterdam UMC, location VUmc | Multiple Sclerosis, Internuclear Ophthalmoplegia | 05/24 | 11/26 | | |
NCT06087757: Clemastine Treatment in Individuals With Williams Syndrome |
|
|
| Recruiting | 3 | 30 | RoW | Open Label Clemastine with a blinded randomize withdrawal | Sheba Medical Center, Tel Aviv University | Williams Syndrome | 12/24 | 12/25 | | |
